systemic lupus erythematosus
GPTKB entity
Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:healthcare_organization
|
| gptkbp:affects |
gptkb:healthcare_organization
gptkb:skincare_product kidneys lungs joints |
| gptkbp:associated_with |
gptkb:Raynaud's_phenomenon
fibromyalgia thyroid disease antiphospholipid syndrome |
| gptkbp:caused_by |
environmental factors
genetic factors hormonal factors |
| gptkbp:complications |
gptkb:healthcare_organization
gptkb:hospital infections heart disease kidney damage blood disorders nervous system issues |
| gptkbp:current_use |
gptkb:Raynaud's_phenomenon
gptkb:Sjogren's_syndrome antiphospholipid syndrome |
| gptkbp:first_described_by |
gptkb:19th_century
|
| gptkbp:historical_figure |
gptkb:Eugene_K._Wong
gptkb:Mary_E._K._H._Wong gptkb:Sir_William_Osler gptkb:Thomas_Addison Hugh Mc Devitt |
| https://www.w3.org/2000/01/rdf-schema#label |
systemic lupus erythematosus
|
| gptkbp:influenced_by |
stress management
sun protection exercise recommendations smoking cessation diet changes |
| gptkbp:is_popular_in |
more common in women
often diagnosed in young adults |
| gptkbp:is_tested_for |
complement levels
anti-Smith antibody test anti-double-stranded DNA test anti-nuclear antibody test |
| gptkbp:public_awareness |
Lupus Awareness Month
|
| gptkbp:research_focus |
biomarkers
new therapies disease mechanisms pathogenesis |
| gptkbp:social_responsibility |
blood tests
urinalysis biopsy |
| gptkbp:symptoms |
fatigue
fever joint pain hair loss skin rashes |
| gptkbp:treatment |
improve quality of life
corticosteroids nonsteroidal anti-inflammatory drugs immunosuppressants reduce inflammation manage symptoms prevent flares |